- Home
- SBLK vs ARWR Comparison
SBLK vs ARWR Comparison
Compare SBLK & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBLK
- ARWR
- Stock Information
- Founded
- SBLK 2006
- ARWR 2003
- Country
- SBLK Greece
- ARWR United States
- Employees
- SBLK N/A
- ARWR N/A
- Industry
- SBLK Marine Transportation
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- SBLK Consumer Discretionary
- ARWR Health Care
- Exchange
- SBLK Nasdaq
- ARWR Nasdaq
- Market Cap
- SBLK 1.9B
- ARWR 1.8B
- IPO Year
- SBLK N/A
- ARWR 1993
- Fundamental
- Price
- SBLK $16.80
- ARWR $15.62
- Analyst Decision
- SBLK Strong Buy
- ARWR Buy
- Analyst Count
- SBLK 3
- ARWR 9
- Target Price
- SBLK $22.67
- ARWR $43.71
- AVG Volume (30 Days)
- SBLK 1.4M
- ARWR 1.6M
- Earning Date
- SBLK 08-06-2025
- ARWR 08-07-2025
- Dividend Yield
- SBLK 8.58%
- ARWR N/A
- EPS Growth
- SBLK N/A
- ARWR N/A
- EPS
- SBLK 1.96
- ARWR N/A
- Revenue
- SBLK $1,236,718,000.00
- ARWR $545,209,000.00
- Revenue This Year
- SBLK N/A
- ARWR $21,924.50
- Revenue Next Year
- SBLK $14.96
- ARWR N/A
- P/E Ratio
- SBLK $8.56
- ARWR N/A
- Revenue Growth
- SBLK 25.60
- ARWR 1436.97
- 52 Week Low
- SBLK $12.06
- ARWR $9.57
- 52 Week High
- SBLK $25.25
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- SBLK 57.82
- ARWR 49.46
- Support Level
- SBLK $16.39
- ARWR $15.19
- Resistance Level
- SBLK $17.56
- ARWR $16.06
- Average True Range (ATR)
- SBLK 0.37
- ARWR 0.69
- MACD
- SBLK -0.00
- ARWR -0.21
- Stochastic Oscillator
- SBLK 55.81
- ARWR 18.87
About SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.